RNA modified with acyclic threoninol nucleic acids for RNA interference

DOI: 10.14800/rd.907

Authors

  • Adele Alagia, Montserrat Terrazas, Ramon Eritja

Abstract

Upon the discovery of the RNA interference pathway, the development of nucleic acids derivatives for therapeutic purposes has soon caught the attention of biomedical researchers. Although synthetic small interfering RNA (siRNA) has been extensively used to downregulate any protein-coding mRNA, several key issues still remain unsolved. The acyclic threoninol nucleic acid (aTNA), placed at certain siRNA positions, is a useful modification to reduce the oligonucleotides vulnerability towards nucleases. In addition, it can be exploited to avoid several OFF-target effects that limit the biological safety of the RNAi-based agents.

Downloads

Published

2016-02-18

Issue

Vol. 3 (2016)

Section

Review